Pediatrix Medical Group, Inc. (MD) | Rumor.io

Pediatrix Medical Group

Attention (50-day avg)0%

Attention rank (50-day avg)#2,361

Bullish sentiment (50-day avg)100%

Price to earnings ratio12.4

Market capitalization2.1B

Earnings per share2.09

Dividend yield (TTM)—

Revenue (annual)1.9B

Net income (annual)165.4M

Social

What share of all stock conversation is about MD?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Feb 19

Pediatrix Medical Group (MD) reported Q4 2025 earnings with a GAAP EPS of $0.40, up 11.11% YoY, and revenue of $493.77M, down -1.71% YoY.
The company anticipates 2026 Adjusted EBITDA to be in a range of $280M to $300M, reflecting its outlook for the upcoming fiscal year.
Pediatrix Medical Group's Q4 performance was mixed, with strong adjusted EBITDA but a decrease in total revenue due to practice dispositions, leading to a decline in shares.

Generated by AI

Sentiment

Of the messages about MD that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	98.84% +8.87
Bearish	—	—	—	1.16% -8.87

Apr 26

Mednax's sale process is struggling due to a complex accounting issue with contracts with healthcare providers.
Short-seller Jim Chanos has bet against Mednax, citing concerns about the company's accounting practices and suggesting it may be worth nothing.
Mednax has been downgraded by TheStreet and is facing a potential collapse in value, possibly due to private equity firms losing interest in the company.

Generated by AI

Topics

Of the messages about MD that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0.91%
Announcements	—	—	—	62.73%
Controversies	—	—	—	0%
Earnings	—	—	—	7.27%
Macro	—	—	—	0%
Technical Analysis	—	—	—	29.09%

Jul 28

Pediatrix Medical Group, Inc. ($MD) reported FQ2 earnings of 85c EPS and $842.94M in revenue, missing revenue estimates by $7.63M.
The company's Q3 EPS guidance is set at $0.83-0.88, excluding non-recurring items, which falls below Wall Street's expectations of $0.98.
Pediatrix Medical Group, Inc. ($MD) missed EPS estimates by $0.02 and revenue estimates, with earnings of $0.85 per share and $843.00M in revenue.

Generated by AI

Community

Of the messages about MD, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	41.28%
Newcomers	—	—	—	58.72%

Regulars· May 2

Pediatrix Medical Group has reported mixed Q1 earnings, with a non-GAAP EPS of $0.17, GAAP EPS of $0.17, and revenue of $491M.
The company has reaffirmed its FY23 outlook despite the mixed Q1 results.
Pediatrix Medical Group's Q1 2023 earnings call transcript is available, providing further insight into the company's performance.

Newcomers· Nov 3

Newcomers are focusing on the stock's potential for growth, with some thinking it could go even higher.
The company's focus on high-risk neonatal and maternal care creates a natural competitive moat and provides a long-term runway for growth through strategic mergers and acquisitions.
The stock has seen significant gains after reporting Q3 revenue and adjusted EPS, and has formed a new base above the $20 level, showing signs of steady institutional absorption.

Generated by AI

News

Can Pediatrix Sustain Growth Despite Lower Patient Volumes?

MD posts 4% year-over-year revenue growth in the second quarter of 2026 despite lower patient volumes, aided by stronger reimbursement and acquisitions.

7d agoYahoo Finance

Pediatrix Medical Group (MD) Could Be 2% Below Fair Value Following Its Pullback

Pediatrix Medical Group (MD) has drawn fresh attention after trading around a recent close of US$25.93. Investors are weighing this level against the company’s longer term return record and its current healthcare services footprint. Recent trading has been choppy for Pediatrix Medical Group, with a 1-day share price return of 1.73% offsetting some of the pressure from a 7-day share price return that slipped 3.64%. At the same time, the year-to-date share price return of 21.79% and a 1-year...

9d agoYahoo Finance

Pediatrix (MD) Grows Earnings Even As Patient Volumes Keep Falling

On August 4, Pediatrix Medical Group (NYSE:MD) reported second-quarter results that look strong on the surface. Adjusted earnings per share jumped to $0.63 from $0.53, and net revenue grew to $487.8 million. But look past the headline numbers, and the growth is coming largely from pricing and a shrinking share count, not from more patients […]

14d agoYahoo Finance

Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?

Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

26d agofinance.yahoo.com

Q2 Earnings Highlights: Pediatrix Medical Group (NYSE:MD) Vs The Rest Of The Healthcare Providers & Services Stocks

Looking back on healthcare providers & services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Pediatrix Medical Group (NYSE:MD) and its peers.

1mo agoYahoo Finance

Why is Pediatrix Medical stock slipping today?

1mo agoInvesting.com

Also Discussed

Investors talking about MD also mention

#	Name	Attention
1	Phathom Pharmaceuticals, Inc.PHAT	0%new
2	Veradigm Inc.MDRX	0%0
3	LHCG - LHC Group, Inc.	——
4	Acadia Healthcare Company, Inc.ACHC	0%new
5	The Cigna GroupCI	0%0
6	The Middleby CorporationMIDD	0%new
7	AMED - Amedisys, Inc.	——
8	U.S. Physical Therapy, Inc.USPH	0%0
9	Not in Employment, Education, or TrainingNEET	0.01%+0
10	OSH - Oak Street Health, Inc.	——

Pediatrix Medical Group, Inc.

Healthcare
Medical Care Facilities

Pediatrix Medical Group, Inc. operates as a leading provider of physician services within the broader healthcare sector, focusing specifically on neonatal, maternal-fetal, pediatric cardiology, and other related areas. The primary purpose of Pediatrix Medical Group is to ensure specialized and high-quality healthcare for women and children, prioritizing the critical care aspects that are often underserved. Notable for their comprehensive service offerings, Pediatrix plays an essential role in hospital-based management, offering an array of services including clinical staffing, administrative support, and healthcare management solutions. The company's impact on the healthcare industry is significant, as it supports both hospitals and clinics across the United States in delivering superior patient care. As a specialized provider, Pediatrix Medical Group holds a crucial position in addressing the healthcare needs of vulnerable populations, contributing to improved outcomes in neonatal and pediatric care sectors. This strengthens their market significance as they help meet the growing demand for specialized medical services in a dynamic healthcare environment.

Website

Location

1301 Concord Terrace

Sunrise, FL, 33323

United States

Social

What share of all stock conversation is about MD?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Feb 19

Pediatrix Medical Group (MD) reported Q4 2025 earnings with a GAAP EPS of $0.40, up 11.11% YoY, and revenue of $493.77M, down -1.71% YoY.
The company anticipates 2026 Adjusted EBITDA to be in a range of $280M to $300M, reflecting its outlook for the upcoming fiscal year.
Pediatrix Medical Group's Q4 performance was mixed, with strong adjusted EBITDA but a decrease in total revenue due to practice dispositions, leading to a decline in shares.

Generated by AI

Sentiment

Of the messages about MD that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	98.84% +8.87
Bearish	—	—	—	1.16% -8.87

Apr 26

Mednax's sale process is struggling due to a complex accounting issue with contracts with healthcare providers.
Short-seller Jim Chanos has bet against Mednax, citing concerns about the company's accounting practices and suggesting it may be worth nothing.
Mednax has been downgraded by TheStreet and is facing a potential collapse in value, possibly due to private equity firms losing interest in the company.

Generated by AI

Topics

Of the messages about MD that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0.91%
Announcements	—	—	—	62.73%
Controversies	—	—	—	0%
Earnings	—	—	—	7.27%
Macro	—	—	—	0%
Technical Analysis	—	—	—	29.09%

Jul 28

Pediatrix Medical Group, Inc. ($MD) reported FQ2 earnings of 85c EPS and $842.94M in revenue, missing revenue estimates by $7.63M.
The company's Q3 EPS guidance is set at $0.83-0.88, excluding non-recurring items, which falls below Wall Street's expectations of $0.98.
Pediatrix Medical Group, Inc. ($MD) missed EPS estimates by $0.02 and revenue estimates, with earnings of $0.85 per share and $843.00M in revenue.

Generated by AI

Community

Of the messages about MD, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	41.28%
Newcomers	—	—	—	58.72%

Regulars· May 2

Pediatrix Medical Group has reported mixed Q1 earnings, with a non-GAAP EPS of $0.17, GAAP EPS of $0.17, and revenue of $491M.
The company has reaffirmed its FY23 outlook despite the mixed Q1 results.
Pediatrix Medical Group's Q1 2023 earnings call transcript is available, providing further insight into the company's performance.

Newcomers· Nov 3

Newcomers are focusing on the stock's potential for growth, with some thinking it could go even higher.
The company's focus on high-risk neonatal and maternal care creates a natural competitive moat and provides a long-term runway for growth through strategic mergers and acquisitions.
The stock has seen significant gains after reporting Q3 revenue and adjusted EPS, and has formed a new base above the $20 level, showing signs of steady institutional absorption.

Generated by AI

Pediatrix Medical Group

Social

Feb 19

Apr 26

Jul 28

Regulars· May 2

Newcomers· Nov 3

Can Pediatrix Sustain Growth Despite Lower Patient Volumes?

Pediatrix Medical Group (MD) Could Be 2% Below Fair Value Following Its Pullback

Pediatrix (MD) Grows Earnings Even As Patient Volumes Keep Falling

Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?

Q2 Earnings Highlights: Pediatrix Medical Group (NYSE:MD) Vs The Rest Of The Healthcare Providers & Services Stocks

Why is Pediatrix Medical stock slipping today?

Also Discussed

Pediatrix Medical Group, Inc.

Company Information

Location

Can Pediatrix Sustain Growth Despite Lower Patient Volumes?

Pediatrix Medical Group (MD) Could Be 2% Below Fair Value Following Its Pullback

Pediatrix (MD) Grows Earnings Even As Patient Volumes Keep Falling

Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?

Q2 Earnings Highlights: Pediatrix Medical Group (NYSE:MD) Vs The Rest Of The Healthcare Providers & Services Stocks

Why is Pediatrix Medical stock slipping today?

Also Discussed

Social

Feb 19

Apr 26

Jul 28

Regulars· May 2

Newcomers· Nov 3